We are live on ! Find out more
BHC icon

Bausch Health

352 hedge funds and large institutions have $7.75B invested in Bausch Health in 2021 Q1 according to their latest regulatory filings, with 68 funds opening new positions, 92 increasing their positions, 126 reducing their positions, and 50 closing their positions.

New
Increased
Maintained
Reduced
Closed

58% more capital invested

Capital invested by funds: $4.89B → $7.75B (+$2.86B)

54% more funds holding in top 10

Funds holding in top 10: 1320 (+7)

36% more first-time investments, than exits

New positions opened: 68 | Existing positions closed: 50

22% more call options, than puts

Call options by funds: $304M | Put options by funds: $248M

4% more funds holding

Funds holding: 338352 (+14)

2.48% more ownership

Funds ownership: 65.95%68.43% (+2.5%)

27% less repeat investments, than reductions

Existing positions increased: 92 | Existing positions reduced: 126

Holders
352
Holders Change
+14
Holders Change %
+4.14%
% of All Funds
6.18%
Holding in Top 10
20
Holding in Top 10 Change
+7
Holding in Top 10 Change %
+53.85%
% of All Funds
0.35%
New
68
Increased
92
Reduced
126
Closed
50
Calls
$304M
Puts
$248M
Net Calls
+$55.3M
Net Calls Change
+$12.7M
Name Holding Trade Value Shares
Change
Change in
Stake
Goldman Sachs
51
Goldman Sachs
New York
$25.2M -$5.11M -174,359 -18%
GI
52
GAMCO Investors
Connecticut
$24.3M -$293K -9,997 -1%
New York State Common Retirement Fund
53
New York State Common Retirement Fund
New York
$23.3M
Renaissance Technologies
54
Renaissance Technologies
New York
$23.1M -$37M -1,260,800 -63%
MDSL
55
M.D. Sass LLC
New York
$22.8M -$12.1M -410,909 -36%
TB
56
Terril Brothers
Missouri
$22M -$917K -31,280 -4%
Geode Capital Management
57
Geode Capital Management
Massachusetts
$19.7M +$993K +33,861 +6%
Two Sigma Advisers
58
Two Sigma Advisers
New York
$19.6M +$10.8M +369,900 +150%
Voloridge Investment Management
59
Voloridge Investment Management
Florida
$18.1M +$16.7M +569,732 New
CS
60
Credit Suisse
Switzerland
$17M -$3.88M -132,332 -20%
PPA
61
Parametric Portfolio Associates
Washington
$16.4M +$73.7K +2,511 +0.5%
KHCM
62
Kettle Hill Capital Management
New York
$16.1M +$14.9M +506,866 New
Fidelity Investments
63
Fidelity Investments
Massachusetts
$15.9M -$3.41M -116,276 -19%
Schroder Investment Management Group
64
Schroder Investment Management Group
United Kingdom
$15.5M -$8.01M -273,057 -41%
GF
65
Gabelli Funds
New York
$15.1M +$896K +30,555 +7%
DCM
66
Driehaus Capital Management
Illinois
$14.8M +$2.23M +76,095 +20%
Walleye Trading
67
Walleye Trading
New York
$14.6M +$9.28M +316,389 +218%
VanEck Associates
68
VanEck Associates
New York
$14.5M +$2.76M +94,057 +26%
Invesco
69
Invesco
Georgia
$14.2M -$5.49M -187,307 -29%
Bank of New York Mellon
70
Bank of New York Mellon
New York
$14.2M -$1.8M -61,233 -12%
SAM
71
Silvercrest Asset Management
New York
$14.1M +$1.18M +40,228 +10%
CCM
72
Cobalt Capital Management
New Jersey
$13.6M +$3.29M +112,000 +35%
GCM
73
Glendon Capital Management
California
$12.7M -$1.58M -53,801 -12%
ECM
74
ExodusPoint Capital Management
New York
$12.5M +$10.3M +351,477 +801%
BCC
75
Biglari Capital Corp
Texas
$12.5M

BHC Hedge Fund Activity: Q1 2021 in Review

352 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Bausch Health (BHC) for Q1 2021, worth a combined $7.75B — up 58% from $4.89B a quarter earlier.

Buyers outnumbered sellers: 68 funds opened new BHC positions and 50 closed out — a net gain of 18 holders — while 92 added to existing stakes and 126 trimmed.

The largest buyer was Icahn Carl, adding an estimated $853M. The largest seller was Permian Investment Partners, cutting an estimated $90.4M.

  • 352 institutional investors held Bausch Health (BHC) as of Q1 2021, up from 338 in Q4 2020.
  • Funds reported $7.75B of Bausch Health stock for Q1 2021, up 58% quarter-over-quarter.
  • 68 funds opened new Bausch Health positions in Q1 2021 and 50 closed out, a net change of +18 holders.
  • The largest Bausch Health buyer in Q1 2021 was Icahn Carl, an estimated $853M added.
  • The largest Bausch Health seller in Q1 2021 was Permian Investment Partners, an estimated $90.4M sold.

Based on aggregated 13F filings for Q1 2021.